Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 10 New Entrants companies in Levodopa
by Most Patent Filing In 1 Year in the world in 2018

The Levodopa top 10 is Discovery PatSnap’ annual ranking of the top 10 Most Patent Filing In 1 Year Levodopa New Entrants in the world. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2018, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
l-DOPA, also known as levodopa and l-3,4-dihydroxyphenylalanine, is an amino acid that is made and used as part of the normal biology of humans, as well as some animals and plants. Humans, as well as a portion of the other animals that utilize l-DOPA in their biology, make it via biosynthesis from the amino acid l-tyrosine. l-DOPA is the precursor to the neurotransmitters dopamine, norepinephrine (noradrenaline), and epinephrine (adrenaline), which are collectively known as catecholamines. Furthermore, l-DOPA itself mediates neurotrophic factor release by the brain and CNS. l-DOPA can be manufactured and in its pure form is sold as a psychoactive drug with the INN levodopa; trade names include Sinemet, Pharmacopa, Atamet, Stalevo, Madopar, and Prolopa. As a drug, it is used in the clinical treatment of Parkinson's disease and dopamine-responsive dystonia.
#
Company Name
Region
Tech Topics
Total
1
Tel Aviv, Israel
Patent: 5
2
California, United States
Health care,Pharmacy and Therapeutics,Addiction,
...[+2]
Patent: 5
3
California, United States
Patent: 2
4
Patent: 2
5
California, United States
Biotechnology,Pharmacy and Therapeutics,Biological process,
...[+2]
Patent: 1
6
British Virgin Islands
British Virgin Islands,Asset management
Patent: 1
7
Cataluña, Spain
Public university,Catalan,Kinase,
...[+2]
Patent: 1
8
Patent: 1
9
Patent: 1
10
Patent: 1
Page generation time: Jun 26 2025